|
 |
|
DotNetNuke Script Insertion Vulnerabilities
|
|
|
|
|
Secunia Advisory:
|
SA15397
|
|
|
Release Date:
|
2005-05-17
|
|
|
Critical:
|
Moderately critical
|
|
Impact:
|
Cross Site Scripting
|
|
Where:
|
From remote
|
|
Solution Status:
|
Vendor Patch
|
|
| Software: | DotNetNuke 3.x
|
| | CVE reference: | CVE-2005-0040 (Secunia mirror)
|
|
|
Want to know the next time vulnerabilities are fixed in this product?
- Companies can be alerted via email and SMS! |
|
|
Description:
Mark Woan has reported some vulnerabilities in DotNetNuke, which can be exploited by malicious people to conduct script insertion attacks.
Input passed to the "User-Agent" HTTP header, the username and certain registration data is not properly sanitised before being used. This can be exploited to inject arbitrary HTML and script code, which will be executed in a user's browser session in context of an affected site when the malicious user data is viewed.
The vulnerabilities have been reported in versions prior to 3.0.12.
Solution:
Update to version 3.0.12.
Provided and/or discovered by:
Mark Woan
Original Advisory:
http://www.woany.co.uk/advisories/dotnetnukexss.txt
|
|
|
|
|
Please note: The information that this Secunia Advisory is based on comes from a third party unless stated otherwise.
Secunia collects, validates, and verifies all vulnerability reports issued by security research groups, vendors, and others.
|
|
|
|
4 Related Secunia Security Advisories
|
|
|
1. DotNetNuke Cross-Site Scripting Vulnerabilities
|
|
2. DotNetNuke Cross-Site Scripting Vulnerability
|
|
3. DotNetNuke Multiple Vulnerabilities
|
|
4. DotNetNuke "error" Parameter Cross-Site Scripting Vulnerability
|
|
|
Send Feedback to Secunia
|
|
If you have new information regarding this Secunia advisory or a product in our database, please send it to us using either our web form or email us at vuln@secunia.com.
Ideas, suggestions, and other feedback are most welcome.
|
|
|
|
|
|
Secunia PSI
Scan | Patch | Track
Free Download
|
|
|
Secunia Poll
|
|
|
|
|
 |
|
|
Most Popular Advisories
|
|
|
|
|
|
